Heart rate reduction in coronary artery disease and heart failure

Area of Science:

• Cardiology
• Clinical Medicine
• Pharmacology

Background:

• Elevated heart rate is a known risk factor for myocardial ischemia in coronary artery disease (CAD).
• Heart rate reduction is a recognized strategy to prevent ischemic episodes and angina symptoms.
• High heart rate is a risk factor for cardiovascular events in patients with CAD and heart failure (HF).

Purpose of the Study:

• To critically assess clinical findings on the variable effects of heart rate reduction in cardiovascular disease.
• To evaluate the role of heart rate as a modifiable risk factor in different cardiovascular conditions.
• To propose hypotheses explaining the differential impact of heart rate reduction.

Main Methods:

• Systematic review of clinical evidence and trial data (e.g., SHIFT, SIGNIFY).
• Analysis of the relationship between heart rate, myocardial ischemia, angina, and cardiovascular events.
• Assessment of heart rate's role in cardiac arrhythmias and sudden cardiac death.

Main Results:

• Heart rate reduction improves prognosis in chronic heart failure (HF) (SHIFT trial).
• Heart rate is not a modifiable risk factor in CAD patients without HF (SIGNIFY trial).
• Heart rate influences cardiac arrhythmias; both low and high rates have associated risks.

Conclusions:

• The effect of heart rate reduction varies significantly across cardiovascular conditions.
• Heart rate management strategies should be tailored to specific patient populations (e.g., HF vs. non-HF CAD).
• Further research is needed to elucidate the mechanisms behind the variable response to heart rate reduction.